FINGER; Finland-Germany Myocardial Infarction Study

The purpose of this observational study is to find characteristics and risk stratification methods for identification of subjects who have increased risk of death, especially sudden cardiac death, after acute myocardial infarction.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Acute Myocardial Infarction Death Death, Sudden Pathologic Processes Pathological Conditions, Signs and Symptoms

Sex eligibility

All sexes

Study type

Observational

Primary location

Oulu University Hospital, Oulu, Finland

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Diagnosis of acute myocardial infarction
Consent to the study

Treatment and study plan

No intervention

Other

Primary outcomes

All cause mortality

Time frame: 10years

Secondary outcomes

Sudden cardiac death

Time frame: 10 years

Sponsors and collaborators

Lead sponsor

University of Oulu

Other

Collaborators

Bundesministerium für Bildung, Wissenschaft, Forschung und Technologie
Finnish Foundation for Cardiovascular Research
German Research Foundation
Kommission für Klinische Forschung
Medical Council of the Finnish Academy of Science

Registry information

Official study title

Finnish-German Prospective, Observational Follow-up Study on Risk Assessment of Mortality After Myocardial Infarction

Acronym: FINGER

Important dates

Study start: 1996
Primary completion: 2000
First posted: Jan 26, 2009
Registry last updated: Jan 26, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed